histoindex official1 04 Oct 2017

HistoIndex Receives Frost & Sullivan 2017 Asia-Pacific Best...

Date: 04 Oct 2017

Histoindex Pte. Ltd. has been presented with the 2017 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Diagnostics New Product Innovation Award by Frost & Sullivan. The award is a testament of the achievements by HistoIndex and the impact of its proprietary technologies such as Genesis®200 on aiding clinical diagnosis and the development of NASH therapeutics.

Read More
Signing Photo9 13 Jan 2016

HistoIndex Signs RMB15 million Co-investment Deal with JoinS...

Date: 13 Jan 2016

China-based Qingdao Yaozhu has entered into a joint venture agreement to co-invest with Singapore-headquartered medtech company, HistoIndex®.

Read More

1 2 3